|
Volumn 9, Issue 18, 2002, Pages 1689-1700
|
Structure-activity relationships in the acronycine series
|
Author keywords
[No Author keywords available]
|
Indexed keywords
1,2 DIHYDROACRONYCINE;
1,2 DIHYDROACRONYCINE DERIVATIVE;
1,2 DIHYDROXY 1,2 DIHYDROACRONYCINE DIESTER DERIVATIVE;
1,2 DIHYDROXY 1,2 DIHYDROBENZO[B]ACRONYCINE DIESTER DERIVATIVE;
10 NITRONOACRONYCINE;
10,11 DIMETHOXYACRONYCINE;
11 AMINOACRONYCINE;
11 HYDROXY 12 METHYLSEVERIFOLINE;
11 METHOXYACRONYCINE;
11 NITROACRONYCINE;
11 NITRONOACRONYCINE;
2,2 DIMETHYLCHROMENE DERIVATIVE;
6 (2 DIMETHYLAMINO)ETHOXY 3,3,12 TRIMETHYL 3,12 DIHYDRO 7H PYRANO[2,3 C]ACRIDINE 7 ONE;
6 DEMETHOXYACRONYCINE;
6 HYDROXY 3,3 DIMETHYL 3,14 DIHYDRO 7H BENZO[B]PYRANO[3,2 H]ACRIDIN 7 ONE;
6 METHOXY 3,3 DIMETHYL 3H,7H PYRANO[2,3 C]THIOXANTHEN 7 ONE;
6 METHOXY 3,3 DIMETHYL 3H,7H PYRANO[2,3 C]XANTHEN 7 ONE;
6 METHOXY 3,3,12 TRIMETHYL 3,12 DIHYDROCHROMENO [5,6 B][1,8]NAPHTYRIDIN 7 ONE (11 AZAACRONYCINE);
6 METHOXY 3,3,14 TRIMETHYL 3,14 DIHYDRO 7H BENZO[B]PYRANO[3,2 H]ACRIDIN 7 ONE (BENZO[B]ACRONYCINE);
9 CHLOROACRONYCINE;
9 HYDROXYACRONYCINE;
9 NITRONOACRONYCINE;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ALKALOID;
ATALAPHYLLIDINE;
ATALAPHYLLININE;
N DESMETHYLNORACRONYCINE;
NORACRONINE;
PYRANO[2,3 H]QUINOLONE ACRONYCINE DERIVATIVE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ACRONINE;
DRUG DERIVATIVE;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG ACTIVATION;
DRUG ISOLATION;
DRUG MECHANISM;
DRUG POTENCY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
GASTROINTESTINAL DISEASE;
HUMAN;
HUMAN CELL;
HYPOTHESIS;
MOUSE;
NEUROLOGIC DISEASE;
NONHUMAN;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
REVIEW;
SOLID TUMOR;
STRUCTURE ACTIVITY RELATION;
ANIMAL;
CHEMISTRY;
DRUG SCREENING;
ACRONINE;
ANIMALS;
ANTINEOPLASTIC AGENTS;
DRUG SCREENING ASSAYS, ANTITUMOR;
HUMANS;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 0036024723
PISSN: 09298673
EISSN: None
Source Type: Journal
DOI: 10.2174/0929867023369213 Document Type: Review |
Times cited : (22)
|
References (77)
|